@article{62366718a6ff43d5900c0caa67025130,
title = "2012: The year in dementia",
author = "Sam Gandy and DeKosky, {Steven T.}",
note = "Funding Information: SG has received support of the Cure Alzheimer's Fund, National Institute of Neurological Diseases and Stroke, VA MERIT Review, and research grants from Amicus Therapeutics and Baxter Pharmaceuticals. SG is also supported by National Institute on Aging grant. Within the past 5 years, SG has served on the Scientific Advisory Board of Diagenic Inc, and on the Safety Monitoring Boards for the Pfizer-J&J Alzheimer Immunotherapy Alliance and for Balance Therapeutics. STDeK declares the consultation for or research support from NIA, Elan, Novartis, Janssen, Pfizer, Baxter, Myriad, Neurochem, Genzyme, Helicon Theraputics, Siemens, and GlaxoSmithKline in the past 5 years. STDeK is also supported by NIA grants at the University of Pittsburgh, and chairs the Safety Monitoring Board for the CREST-E study of creatine in Huntington's Disease for the National Center for Complementary and Alternative Medicine (NCCAM). He also serves on the Scientific Advisory Council for NCCAM.",
year = "2013",
month = jan,
doi = "10.1016/S1474-4422(12)70284-3",
language = "English",
volume = "12",
pages = "4--6",
journal = "The Lancet Neurology",
issn = "1474-4422",
publisher = "Elsevier Ltd.",
number = "1",
}